Sandoz submits generic obesity drug applications to FDA
Go back to Sandoz submits generic obesity drug applications to FDA| Lilly (Eli) & Co. (NYSE: LLY) | Delayed: 1163.01 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1163.01 | 52 Week High | $88.16 | |||
| Open | $1163.01 | 52 Week Low | $67.88 | |||
| Day High | $1163.01 | P/E | 269.22 | |||
| Day Low | $1163.01 | EPS | $4.32 | |||
| Volume | 3,597 | |||||
| NOVO-NORDISK A/S (NYSE: NVO) | Delayed: 48.19 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $48.19 | 52 Week High | $59.00 | |||
| Open | $48.19 | 52 Week Low | $32.80 | |||
| Day High | $48.19 | P/E | N/A | |||
| Day Low | $48.19 | EPS | $0.00 | |||
| Volume | 152,536 | |||||
| (AMEX: SDZNY) | Delayed: 78.51 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $78.51 | 52 Week High | $ | |||
| Open | $78.51 | 52 Week Low | $ | |||
| Day High | $78.51 | P/E | N/A | |||
| Day Low | $78.51 | EPS | $ | |||
| Volume | 6,453 | |||||

